AptarGroup, Inc. (ATR)
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies
AptarGroup (ATR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AptarGroup: Strong Pharma And Closure Growth To Offset Beauty Headwinds
AptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. The prescription drug business is expected to drive revenue growth in the Pharma segment. Margin expansion anticipated from operational leverage, cost management, and premium product mix.
Technip Energies awarded major contract for Blue Point Number One ATR, the world's largest low-carbon ammonia production facility
Technip Energies (PARIS:TE) has been awarded a major( 1) contract by Blue Point Number One, a joint venture between CF Industries, JERA, and MITSUI & CO, for the Blue Point Number One ATR Project in Donaldsonville, Louisiana. This project aims to deliver the world's largest low-carbon ammonia plant with a capacity of approximately 1.4 million metric tons per year.
AptarGroup Earnings Surpass Estimates in Q4, Increase 27% Y/Y
ATR's Q4 top line gains from improved performances of the Pharma and Closures segments.
International Markets and AptarGroup (ATR): A Deep Dive for Investors
Explore AptarGroup's (ATR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript
AptarGroup, Inc. (NYSE:ATR ) Q4 2024 Earnings Conference Call February 7, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President, Investor Relations & Communications Stephan Tanda - President & Chief Executive Officer Vanessa Kanu - Executive Vice President & Chief Financial Officer Conference Call Participants George Staphos - Bank of America Ghansham Panjabi - Baird Matt Roberts - Raymond James Daniel Rizzo - Jefferies Matt Larew - William Blair Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. Welcome to Aptar's 2024 Fourth Quarter and Annual Results Conference Call.
AptarGroup (ATR) Tops Q4 Earnings Estimates
AptarGroup (ATR) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.21 per share a year ago.
Aptar Reports Fourth Quarter and Annual 2024 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2024 Results.
AptarGroup (ATR) Reports Next Week: Wall Street Expects Earnings Growth
AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details.
Top 3 Materials Stocks That Are Set To Fly This Month
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
